CenTrial Logo

Reducing Anxiety in Asthma Patients using Respiratory Training


Clinical trial finds that biofeedback training is helpful in reducing anxiety in asthma patients

Anxiety is common among individuals with asthma, and the relationship between asthma symptoms and anxiety can be challenging. Existing treatments for comorbid anxiety and asthma are limited. Hyperventilation, a shared feature of both conditions, negatively impacts lung function and symptoms of asthma and anxiety.

Clinical Trial

A clinical trial investigated whether a treatment targeting hyperventilation could improve anxiety in asthma patients with high anxiety levels. One hundred and twenty adult patients with asthma, who spoke English or Spanish, were randomly assigned to receive either Capnometry-Assisted Respiratory Training (CART) aimed at raising Pco2 levels or feedback to slow respiratory rate (SLOW). While anxiety was not a specific inclusion criterion, 21.7% of participants had clinically significant anxiety levels based on the Hospital Anxiety and Depression Scale (HADS). Anxiety, depression, sensitivity, and negative affect were assessed at baseline, post-treatment, 1-month follow-up, and 6-month follow-up.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me


Asthma patients with high baseline anxiety experienced greater reductions in anxiety sensitivity and negative affect in the CART group compared to the SLOW group. Moreover, at the 6-month follow-up, these patients showed lower anxiety sensitivity, negative affect, and depression scores in the CART group compared to the SLOW group. Patients with low baseline anxiety did not exhibit significant differences in outcomes between the CART and SLOW groups.


Among asthma patients with high anxiety levels, the brief training aimed at raising Pco2 levels resulted in significant and sustained reductions in anxiety sensitivity and negative affect compared to slow-breathing training. These findings support using Pco2 as a potential physiological target for reducing anxiety in asthma patients. By addressing hyperventilation, this treatment approach may offer new possibilities for managing anxiety in individuals with asthma.
Psychosomatic Medicine, Jun-01-23
ClinicalTrials.gov NCT00975273

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

20,000 clinical trials are seeking participants.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.